Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction

Author(s): Panagiota Pietri, Charalambos Vlachopoulos, Dimitris Tousoulis

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 23 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Over the last years, ample data have demonstrated the pivotal role of low-grade inflammation in the pathophysiology of atherosclerosis and cardiovascular disease. It is well established that inflammatory activation, serving either as a substrate, in the chronic phase of atherosclerotic disease, or as a trigger, in the acute phase, increases cardiovascular events. Considering hypertension, the inflammatory process is implicated in its pathophysiology through a bidirectional relationship since arterial hypertension may enhance inflammation and vice versa. Inflammatory biomarkers such as highsensitivity C-reactive protein, have shown predictive value for both the incidence of hypertension and the clinical outcomes in hypertensive patients. In the present review, data on the association between arterial hypertension and low-grade inflammation will be reported and potential pathophysiological pathways and clinical implications underlying this association will be discussed.

Keywords: Anti-inflammatory agents, arterial hypertension, endothelial dysfunction, low-grade inflammation, subclinical organ damage.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 19 April, 2015
Page: [2754 - 2761]
Pages: 8
DOI: 10.2174/0929867322666150420104727
Price: $65

Article Metrics

PDF: 48